HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Innis, B. L. Articles by Hemachudha, C. Search for Related Content PubMed PubMed Citation Articles by Innis, B. L. Articles by Hemachudha, C.

Identification of Continuous Epitopes of the Envelope Glycoprotein of Dengue Type 2 Virus

We reacted 490 hexapeptides homologous to the amino acid sequence of the dengue 2 (DEN-2) virus envelope glycoprotein with antisera from 7 patients with primary DEN-2 virus infections to identify the continuous epitopes recognized by human IgG. There were 124 peptides in 25 clusters (domains) that bound 2 or more antisera. Twenty-two peptides in 7 domains bound all 7 convalescent DEN-2 virus antisera tested, and thus appeared to represent immunodominant epitopes. The evidence that these domains represent continuous epitopes of the envelope glycoprotein is that peptides representing each domain bound multiple sera, peptide reactivity was highly ordered along the amino acid sequence, and in almost all cases, domains were regions of predicted hydrophilicity. Heterologous flavivirus antisera also exhibited binding to the majority of peptides reactive with anti-DEN-2 virus sera, though 4 candidate DEN-2 specific epitopes were identified along with an immunodominant epitope common to dengue, Japanese encephalitis and West Nile viruses. Synthetic peptides representing these epitopes may prove to be useful for a variety of purposes.

This article has been cited by other articles:

				H.-L. Chen, S.-R. Lin, H.-F. Liu, C.-C. King, S.-C. Hsieh, and W.-K. Wang Evolution of Dengue Virus Type 2 during Two Consecutive Outbreaks with an Increase in Severity in Southern Taiwan in 2001-2002 Am J Trop Med Hyg, October 1, 2008; 79(4): 495 - 505. [Abstract] [Full Text] [PDF]

				C.-Y. Lai, W.-Y. Tsai, S.-R. Lin, C.-L. Kao, H.-P. Hu, C.-C. King, H.-C. Wu, G.-J. Chang, and W.-K. Wang Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II J. Virol., July 1, 2008; 82(13): 6631 - 6643. [Abstract] [Full Text] [PDF]

				Y.-C. Chen, H.-N. Huang, C.-T. Lin, Y.-F. Chen, C.-C. King, and H.-C. Wu Generation and Characterization of Monoclonal Antibodies against Dengue Virus Type 1 for Epitope Mapping and Serological Detection by Epitope-Based Peptide Antigens Clin. Vaccine Immunol., April 1, 2007; 14(4): 404 - 411. [Abstract] [Full Text] [PDF]

				R. AnandaRao, S. Swaminathan, S. Fernando, A. M. Jana, and N. Khanna Recombinant Multiepitope Protein for Early Detection of Dengue Infections Clin. Vaccine Immunol., January 1, 2006; 13(1): 59 - 67. [Abstract] [Full Text] [PDF]

				H.-C. Wu, M.-Y. Jung, C.-Y. Chiu, T.-T. Chao, S.-C. Lai, J.-T. Jan, and M.-F. Shaio Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen J. Gen. Virol., October 1, 2003; 84(10): 2771 - 2779. [Abstract] [Full Text] [PDF]